Dyne Therapeutics, Inc. (DYN) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Dyne Therapeutics, Inc. (DYN) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

DYN Income Statement

Dyne Therapeutics, Inc. (DYN) annual income statement — 19-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	0	0	521K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	-521K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	197.07M	181.66M	125.28M	115.61M	113.89M	115.79M	122.37M	97.11M	105.66M	71.96M	69.16M	67.69M	62.27M	66.74M	45.46M	40.15M	42.28M	52.76M	35.78M	51.96M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	35.33M	29.49M	24.39M	20.7M	16.67M	16.55M	15.93M	15.3M	12.86M	9.7M	24.62M	8.84M	7.02M	7.61M	7.93M	6.95M	7.61M	6.09M	7.55M	9.66M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	161.74M	152.17M	100.89M	95.43M	97.22M	99.24M	106.45M	81.81M	92.8M	62.26M	44.54M	58.84M	55.25M	59.13M	37.54M	33.19M	34.67M	46.66M	28.24M	42.3M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	-521K	0	0	0	0	0	0	0	0	0	0	0	1K	0	0	0	0
Operating Income	-197.07M	-181.66M	-125.28M	-116.13M	-113.89M	-115.79M	-122.37M	-97.11M	-105.66M	-71.96M	-69.16M	-67.69M	-62.27M	-66.74M	-45.46M	-40.15M	-42.28M	-52.76M	-35.78M	-51.96M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-73.04%	-56.89%	-2.37%	-19.59%	-7.79%	-60.91%	-76.95%	-43.46%	-69.67%	-7.83%	-52.11%	-68.61%	-47.29%	-26.5%	-27.05%	22.74%	1.14%	-74.89%	-42.37%	-81.68%
EBITDA	-196.47M	-181.1M	-124.73M	-115.61M	-113.37M	-115.29M	-121.87M	-96.66M	-105.22M	-71.56M	-68.77M	-67.29M	-61.84M	-66.31M	-45.05M	-39.74M	-41.88M	-52.3M	-35.36M	-51.62M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-73.3%	-57.09%	-2.34%	-19.61%	-7.74%	-61.1%	-77.21%	-43.65%	-70.14%	-7.93%	-52.65%	-69.31%	-47.66%	-26.79%	-27.42%	23.01%	1.47%	-74.81%	-42.02%	-81.87%
D&A (Non-Cash Add-back)	600K	560K	550K	521K	523K	503K	502K	450K	438K	399K	386K	399K	431K	431K	412K	401K	397K	460K	425K	341K
EBIT	-187.6M	-173.96M	-116.65M	-101.75M	-105.14M	-110.76M	-115.36M	-89.54M	-97.13M	-65.1M	-65.65M	-66.64M	-60.21M	-64.9M	-44.19M	-40.14M	-41.38M	-52.3M	-35.58M	-51.79M
Net Interest Income	3.82M	3.19M	4.55M	4.46M	5.57M	6.53M	7.1M	7.59M	9.28M	7.05M	3M	1.75M	2.19M	2.21M	1.49M	1.34M	903K	441K	230K	182K
Interest Income	9.77M	7.79M	8.76M	7.66M	8.48M	6.63M	7.1M	7.59M	9.28M	7.05M	3M	1.75M	2.19M	2.21M	1.49M	1.34M	903K	441K	230K	182K
Interest Expense	5.95M	4.59M	4.2M	3.19M	2.9M	94K	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	3.52M	3.1M	4.42M	4.17M	5.85M	4.93M	7.01M	7.57M	8.53M	6.86M	3.51M	1.05M	2.06M	1.83M	1.28M	1.32M	894K	451K	200K	174K
Pretax Income	-193.55M	-178.56M	-120.85M	-111.95M	-108.04M	-110.86M	-115.36M	-89.54M	-97.13M	-65.1M	-65.65M	-66.64M	-60.21M	-64.9M	-44.19M	-38.83M	-41.38M	-52.3M	-35.58M	-51.79M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-193.55M	-178.56M	-120.85M	-111.95M	-108.04M	-110.86M	-115.36M	-89.54M	-97.13M	-65.1M	-65.65M	-66.64M	-60.21M	-64.9M	-44.19M	-38.83M	-41.38M	-52.3M	-35.58M	-51.79M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-79.15%	-61.07%	-4.76%	-25.03%	-11.24%	-70.28%	-75.72%	-34.37%	-61.31%	-0.31%	-48.57%	-71.63%	-45.49%	-24.09%	-24.18%	25.02%	2.81%	-74.61%	-42.51%	-80.76%
Net Income (Continuing)	-193.55M	-178.56M	-120.85M	-111.95M	-108.04M	-110.86M	-115.36M	-89.54M	-97.13M	-65.1M	-65.65M	-66.64M	-60.21M	-64.9M	-44.19M	-38.83M	-41.38M	-52.3M	-35.58M	-51.79M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-1.06	-1.08	-0.73	-0.76	-0.76	-0.97	-1.05	-0.88	-0.96	-0.70	-0.81	-1.09	-0.99	-1.08	-0.75	-0.71	-0.78	-1.01	-0.69	-1.00
EPS Growth %	-39.47%	-11.34%	30.48%	13.64%	20.83%	-38.57%	-29.63%	19.27%	3.03%	35.19%	-8%	-53.52%	-26.92%	-6.93%	-8.7%	29%	6.02%	-74.14%	-38%	-56.25%
EPS (Basic)	-1.06	-1.08	-0.73	-0.76	-0.76	-0.97	-1.05	-0.88	-0.96	-0.70	-0.81	-1.09	-0.99	-1.08	-0.75	-0.71	-0.78	-1.01	-0.69	-1.00
Diluted Shares Outstanding	181.77M	165.45M	165.04M	128.44M	141.81M	113.87M	109.91M	101.98M	100.88M	92.51M	81.04M	61.39M	61.11M	59.84M	56.33M	52.47M	51.8M	51.68M	51.6M	51.54M
Basic Shares Outstanding	181.77M	165.45M	165.04M	128.44M	141.81M	113.87M	109.91M	101.98M	100.88M	92.51M	81.04M	61.39M	61.11M	59.84M	56.33M	52.47M	51.8M	51.68M	51.6M	51.54M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-